Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Herpes simplex Infection

  Free Subscription

Articles published in Br J Dermatol

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    February 2023
  1. STEELE L, Innes S, Oldham J, Cunningham M, et al
    Safety outcomes for topical corticosteroid use in eczema herpeticum: a single-centre retrospective cohort study.
    Br J Dermatol. 2023;188:295-297.

    December 2022
  2. GRIFFITHS-ACHA J, Vela-Ganuza M, Sarro-Fuente C, Lopez-Estebaranz JL, et al
    Monkeypox: a new differential diagnosis when addressing genital ulcer disease.
    Br J Dermatol. 2022;187:1050-1052.
    PubMed     Abstract available

    September 2022
  3. SIMPSON EL, Merola JF, Silverberg JI, Reich K, et al
    Safety of Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-blind, Placebo-controlled Phase 2 and Phase 3 Trials.
    Br J Dermatol. 2022 Sep 9. doi: 10.1111/bjd.21867.
    PubMed     Abstract available

    May 2022
  4. PONTES FSC, Pereira GG, da Silva Santos PS, Pontes HAR, et al
    Isotretinoin and herpes simplex virus infection.
    Br J Dermatol. 2022 May 11. doi: 10.1111/bjd.21610.

    April 2022
  5. BIEBER T, Reich K, Paul C, Tsunemi Y, et al
    Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response, Intolerance, or Contraindication to Cyclosporine: Results From a Randomized, Placebo-Control
    Br J Dermatol. 2022 Apr 28. doi: 10.1111/bjd.21630.
    PubMed     Abstract available

    December 2020
  6. XU R, Zhou Y, Cai L, Wang L, et al
    Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19.
    Br J Dermatol. 2020;183:1145-1147.

Thank you for your interest in scientific medicine.

AMEDEO Herpes simplex Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.